Türkmen Neşe Başak, Yüce Hande, Taşlıdere Aslı, Şahin Yasemin, Çiftçi Osman
İnönü University Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Malatya, Turkey
İnönü University Faculty of Medicine, Department of Histology and Embryology, Malatya, Turkey
Turk J Pharm Sci. 2022 Feb 28;19(1):1-8. doi: 10.4274/tjps.galenos.2021.30806.
Thioacetamide (TAA) is an organosulfur, white crystalline compound having liver injury. However, it shows toxic effects on many organs. The reverts the oxidative stress created by TAA on the heart and kidney, and decreased lipid peroxide peroxidation back with antioxidant-properties nerolidol (NRL). This study hypothesized that NRL treatment a potential ameliorate nephrotoxicity and cardiotoxicity caused by TAA.
Thirty-two Wistar Albino male rats (3-4 months old and 280-300 g in weight) were divided into four groups. (a) Control, (b) TAA was administered 200 mg/kg twice a weekly (c) NRL was orally administered at the dose of 100 mg/kg every other day by gavages. (d) TAA and NRL-treated groups were assigned 200 mg/kg TAA and 100 mg/kg NRL for three weeks.
As a result of these dose administration thiobarbituric acid reactive substances (TBARS) levels, superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), and glutathione peroxidase (GPx) levels were detected. The results were shown that TAA leads to a significant rise in TBARS level and a significant decrease in GPx, CAT, SOD, and GSH levels in the heart and kidney tissue according to the control group. The finding of this study the NRL treatment reduced TBARS levels and increased antioxidant level. Administration of NRL prevents the biochemical and histopathological alterations induced by TAA.
The findings of this study show that the antioxidant activity of NRL can protect against biochemical and histological damage caused by TAA in heart and kidney tissue.
硫代乙酰胺(TAA)是一种具有肝损伤作用的有机硫白色结晶化合物。然而,它对许多器官都有毒性作用。橙花叔醇(NRL)具有抗氧化特性,可逆转TAA对心脏和肾脏产生的氧化应激,并降低脂质过氧化水平。本研究假设NRL治疗可能改善TAA引起的肾毒性和心脏毒性。
将32只Wistar白化雄性大鼠(3 - 4月龄,体重280 - 300 g)分为四组。(a)对照组,(b)每周两次给予200 mg/kg TAA,(c)每隔一天经口灌胃给予100 mg/kg NRL,(d)TAA和NRL联合治疗组给予200 mg/kg TAA和100 mg/kg NRL,持续三周。
通过这些剂量给药,检测了硫代巴比妥酸反应性物质(TBARS)水平、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽(GSH)和谷胱甘肽过氧化物酶(GPx)水平。结果显示,与对照组相比,TAA导致心脏和肾脏组织中TBARS水平显著升高,GPx、CAT、SOD和GSH水平显著降低。本研究发现NRL治疗降低了TBARS水平并提高了抗氧化水平。给予NRL可预防TAA诱导的生化和组织病理学改变。
本研究结果表明,NRL的抗氧化活性可保护心脏和肾脏组织免受TAA引起的生化和组织学损伤。